InsiderClue
Insiders · Profile

BARRETT M JAMES

Director at CRESCENT BIOPHARMA · 10% owner at APPIAN · 10% owner at RHYTHM PHARMACEUTICALS · and 5 more. Filing since 4 May 2012. CIK 0001219855

CBIO CRESCENT BIOPHARMA, INC. Director · 4 trades APPN APPIAN CORP 10% owner · 2 trades RYTM RHYTHM PHARMACEUTICALS, INC. 10% owner · 1 trade SENS Senseonics Holdings, Inc. Director · 2 trades ARDX ARDELYX, INC. 10% owner · 6 trades SUPN SUPERNUS PHARMACEUTICALS, INC. Director · 11 trades GYRE GYRE THERAPEUTICS, INC. 10% owner · 3 trades GRPN Groupon, Inc. 10% owner · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CBIO CRESCENT BIOPHARMA, INC.
10 May 2018
Director
Sold, plan not stated
9,539
$169.89K
0.2%
APPN APPIAN CORP
27 Nov 2017
10% owner
Sold, plan not stated
569,620
$11.10M
100%
APPN APPIAN CORP
20 Nov 2017
10% owner
Sold, plan not stated
2,820,516
$54.97M
100%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
10% owner
Bought
550,000
$9.35M
12.6%
SENS Senseonics Holdings, Inc.
1 Jun 2017
Director
Bought
7,092,198
$10.00M
47.9%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,650
$6.67M
9.6%
SENS Senseonics Holdings, Inc.
23 Mar 2016
Director
Bought
1,578,947
$4.50M
11.9%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
6.7%
SUPN SUPERNUS PHARMACEUTICALS, INC.
8 Dec 2015
Director
Sold, plan not stated
70,913
$1.05M
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
7 Dec 2015
Director
Sold, plan not stated
71,067
$1.02M
50.1%
SUPN SUPERNUS PHARMACEUTICALS, INC.
4 Dec 2015
Director
Sold, plan not stated
70,990
$1.03M
33.3%
SUPN SUPERNUS PHARMACEUTICALS, INC.
25 Nov 2015
Director
Sold, plan not stated
16,179
$264.49K
18.0%
SUPN SUPERNUS PHARMACEUTICALS, INC.
18 Nov 2015
Director
Sold, plan not stated
43,000
$709.54K
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
17 Nov 2015
Director
Sold, plan not stated
50,000
$835.46K
53.8%
SUPN SUPERNUS PHARMACEUTICALS, INC.
16 Nov 2015
Director
Sold, plan not stated
19,650
$317.04K
17.4%
CBIO CRESCENT BIOPHARMA, INC.
16 Nov 2015
Director
Sold, plan not stated
452
$3.12K
0.0%
SUPN SUPERNUS PHARMACEUTICALS, INC.
13 Nov 2015
Director
Sold, plan not stated
100,000
$1.63M
47.0%
SUPN SUPERNUS PHARMACEUTICALS, INC.
17 Jun 2015
Director
Sold, plan not stated
111,881
$1.83M
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
16 Jun 2015
Director
Sold, plan not stated
55,105
$928.67K
33.0%
ARDX ARDELYX, INC.
5 Jun 2015
10% owner
Bought
1,869,159
$20.00M
33.3%
ARDX ARDELYX, INC.
26 Dec 2014
10% owner
Sold, plan not stated
1,972
$41.96K
100%
ARDX ARDELYX, INC.
26 Dec 2014
10% owner
Sold, plan not stated
296
$6.38K
100%
ARDX ARDELYX, INC.
26 Dec 2014
10% owner
Sold, plan not stated
296
$6.38K
100%
CBIO CRESCENT BIOPHARMA, INC.
15 Jan 2014
Director
Bought
512,500
$4.10M
14.3%
CBIO CRESCENT BIOPHARMA, INC.
15 Jan 2014
Director
Bought
487,500
$3.90M
12.2%
GYRE GYRE THERAPEUTICS, INC.
5 Dec 2013
10% owner
Sold, plan not stated
1,000
$5.13K
100%
GYRE GYRE THERAPEUTICS, INC.
3 Dec 2013
10% owner
Sold, plan not stated
15,000
$80.75K
100%
GYRE GYRE THERAPEUTICS, INC.
21 Nov 2013
10% owner
Sold, plan not stated
5,333
$27.53K
84.2%
GRPN Groupon, Inc.
15 Aug 2013
10% owner
Sold, plan not stated
27,595
$269.63K
100%
GRPN Groupon, Inc.
15 Aug 2013
10% owner
Sold, plan not stated
3,846
$37.58K
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
4 May 2012
Director
Bought
4,400,000
$22.00M
70.5%
31 decisions on file.